An assets sale is tipped as the next move for the embattled pathology provider.
An assets sale is tipped as the next move for the embattled pathology provider.
End of content
No more pages to load
From The Source
- Medibank ramps up real-time intervention to retain insurance customers
- Digitalised primary care in the UK: a qualitative study of the experiences of minoritised ethnic communities
- EMPHN Strategic Plan 2025-2028
- AMPLIA ENTERS INTO PRECLINICAL COLLABORATION WITH KOREAN SPECIALIST DRUG SCREENING COMPANY NEXT&BIO
- Neuren announces A$50 million on-market share buy-back program
- TGA and InstantScripts reach settlement
- DoHAC: National anti-vaping program for young Australians
- Designs unveiled for new Maitland Mental Health facility
- Increased support for women with severe menopause symptoms
- Tamworth Hospital receives $415,000 for facility upgrades
- NSW to rollout new free RSV prevention program in 2025
- Narrabri Hospital to receive $70,000 for outdoor upgrades